Research on a single molecule signal amplification strategy for high risk HPV mRNA based on fluorescent microarray...

Area of Science:

• Molecular Diagnostics
• Biotechnology
• Medical Microbiology

Background:

• High-risk human papillomavirus (HPV) infections are a major cause of cervical cancer.
• Accurate and sensitive detection of HPV types is crucial for effective screening and patient management.
• Existing diagnostic methods may face limitations in high-throughput capacity and multiplexing capabilities.

Purpose of the Study:

• To develop and validate a high-sensitivity single-molecule signal amplification approach for detecting high-risk HPV mRNA.
• To establish a fluorescent microarray platform (FMP) capable of high-throughput, concurrent detection of multiple HPV types.
• To evaluate the clinical performance of the FMP for identifying single and multiple HPV infections, including HPV16 and HPV18.

Main Methods:

• Utilized modified entropy-driven chain substitution (EDC) for signal amplification on a fluorescent microarray platform.
• Designed the FMP for simultaneous detection of 13 high-risk HPV types, including HPV16 and HPV18.
• Conducted clinical validation to assess sensitivity, specificity, and accuracy in distinguishing coexisting HPV types.

Main Results:

• The FMP demonstrated over 90% sensitivity and specificity in clinical validation.
• Detection sensitivity for HPV16 and HPV18 E6/E7 mRNA exceeded 95%, with specificity nearing 100%.
• The platform accurately identified multiple coexisting HPV types without cross-reactivity, confirming its robustness.

Conclusions:

• The developed fluorescence-based platform offers a scalable and precise solution for high-throughput HPV screening.
• The FMP provides a reliable method for diagnosing single and multiple high-risk HPV infections.
• This technology holds significant potential for large-scale HPV diagnostics, particularly in resource-limited settings.